Follow
Olga E. Lazareva
Olga E. Lazareva
Other namesOlga Lazareva
German Cancer Research Center (Deutsche Krebsforschungszentrum - DKFZ))
Verified email at dkfz-heidelberg.de
Title
Cited by
Cited by
Year
SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype
D Bongiovanni, M Klug, O Lazareva, S Weidlich, M Biasi, S Ursu, S Warth, ...
Cell death & disease 12 (1), 50, 2021
882021
Network medicine for disease module identification and drug repurposing with the NeDRex platform
S Sadegh, J Skelton, E Anastasi, J Bernett, DB Blumenthal, G Galindez, ...
Nature Communications 12 (1), 6848, 2021
522021
The AIMe registry for artificial intelligence in biomedical research
J Matschinske, N Alcaraz, A Benis, M Golebiewski, DG Grimm, L Heumos, ...
Nature methods 18 (10), 1128-1131, 2021
442021
On the limits of active module identification
O Lazareva, J Baumbach, M List, DB Blumenthal
Briefings in Bioinformatics 22 (5), bbab066, 2021
352021
BiCoN: Network-constrained biclustering of patients and omics data
O Lazareva, S Canzar, K Yuan, J Baumbach, DB Blumenthal, P Tieri, ...
Bioinformatics, 2020
212020
Machine learning for deciphering cell heterogeneity and gene regulation
M Scherer, F Schmidt, O Lazareva, J Walter, J Baumbach, MH Schulz, ...
Nature Computational Science 1 (3), 183-191, 2021
162021
Lipid network and moiety analysis for revealing enzymatic dysregulation and mechanistic alterations from lipidomics data
TD Rose, N Köhler, L Falk, L Klischat, OE Lazareva, JK Pauling
Briefings in Bioinformatics 24 (1), bbac572, 2023
112023
Platelet surface protein expression and reactivity upon TRAP stimulation after BNT162b2 vaccination
M Klug, O Lazareva, K Kirmes, M Rosenbaum, M Lukas, S Weidlich, ...
Thrombosis and Haemostasis 122 (10), 1706-1711, 2021
112021
A systematic comparison of novel and existing differential analysis methods for CyTOF data
L Arend, J Bernett, Q Manz, M Klug, O Lazareva, J Baumbach, ...
Briefings in Bioinformatics 23 (1), bbab471, 2022
62022
SARS‑CoV‑2 infection is associated with a pro‑thrombotic platelet phenotype. Cell Death Dis. 2021; 12: 50
D Bongiovanni, M Klug, O Lazareva, S Weidlich, M Biasi, S Ursu, S Warth, ...
Epub 2021/01/09. 10.1038/s41419-020-03333-9, 0
6
Drugst. One-A plug-and-play solution for online systems medicine and network-based drug repurposing
A Maier, M Hartung, M Abovsky, K Adamowicz, GD Bader, S Baier, ...
Arxiv, 2023
42023
Mass cytometry of platelet-rich plasma: a new approach to analyze platelet surface expression and reactivity
M Klug, K Kirmes, J Han, O Lazareva, M Rosenbaum, G Viggiani, ...
Platelets 33 (6), 841-848, 2022
42022
DysRegNet: Patient-specific and confounder-aware dysregulated network inference
O Lazareva, Z Louadi, J Kersting, J Baumbach, DB Blumenthal, M List
BioRxiv, 2022.04. 29.490015, 2022
42022
Platelet expression and reactivity after BNT162b2 vaccine administration
M Klug, O Lazareva, K Kirmes, M Rosenbaum, M Lukas, S Weidlich, ...
medRxiv, 2021.05. 18.21257324, 2021
42021
Multi-omics analysis in a network context
O Lazareva, M Lautizi, A Fenn, M List, T Kacprowski, J Baumbach
Systems Medicine, 224-233, 2021
42021
TF-Prioritizer: a Java pipeline to prioritize condition-specific transcription factors
M Hoffmann, N Trummer, L Schwartz, J Jankowski, HK Lee, LL Willruth, ...
GigaScience 12, giad026, 2023
32023
DysRegNet: Patient-specific and confounder-aware dysregulated network inference
J Kersting, O Lazareva, Z Louadi, J Baumbach, DB Blumenthal, M List
Genetoberfest 2023, 2023
2023
Streamlining and generalizing network-based drug discovery with NeDRex and Drugst. One
FM Delgado-Chaves, S Sadegh, J Skelton, A Maier, M Hartung, ...
RExPO23, 2023
2023
HIPSD&R-seq enables scalable genomic copy number and transcriptome profiling
O Lazareva, JP Malm, M Simovic-Lorenz, G Philippos, P Sant, U Parekh, ...
bioRxiv, 2023.10. 09.561487, 2023
2023
CYANUS-a web platform for analyzing drug response markers in cytometry data
L Arend, J Bernett, Q Manz, M Klug, O Lazareva, J Baumbach, ...
RExPO22, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20